Acceptance of improved Down's syndrome best questioned
This article was originally published in Clinica
A UK research team has developed a screening method for Down's syndrome that could detect many more cases of the disorder than current techniques and reduce the number of pregnant women who need to have an invasive amniocentesis test. However, experts said the new method, which integrates measurements from first- and second-trimester screening tests, is unlikely to gain wide acceptance as it would delay a woman's ability to decide whether or not to terminate the pregnancy.
You may also be interested in...
ConMed Corp. is company of two halves ̶ general surgery and orthopedics – and is readying itself for a renewed assault on these two markets on the back of a technology pipeline, targeted acquisitions and a new growth-winning culture, says CFO Todd Garner.
Drug pricing and access issues expose the pharmaceutical sector especially acutely to calls for companies to meet ethical and social goals, alongside commercial ones. Digital is up-ending pharma’s processes, its workplaces and its consumers. R&D productivity is spluttering. Amid this turmoil, CEOs highlight company culture – the way an organization behaves – as a crucial ingredient for success. But what is a “right” culture? Organizational culture is neither static nor singular. It is continuously influenced by acquisitions, markets, new technologies and new generations. And pharma’s history suggests that culture change cannot happen without sufficient people change.